Global Self-Monitoring Blood Glucose (SMBG) Devices Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2031

According to our (Global Info Research) latest study, the global Self-Monitoring Blood Glucose (SMBG) Devices market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.

Self-monitoring of blood glucose (SMBG) is an important component of modern therapy for diabetes mellitus. SMBG has been recommended for people with diabetes and their health care professionals in order to achieve a specific level of glycemic control and to prevent hypoglycemia. The goal of SMBG is to collect detailed information about blood glucose levels at many time points to enable maintenance of a more constant glucose level by more precise regimens. It can be used to aid in the adjustment of a therapeutic regimen in response to blood glucose values and to help individuals adjust their dietary intake, physical activity, and insulin doses to improve glycemic control on a day-to-day basis.

In Thailand Roche monopolizes Self-Monitoring Blood Glucose (SMBG) Devices market, holding a share over 55%.

Central is the largest market, with a share over 45%, followed by Northern and Northeastern, have a share about 40 percent.

In terms of product, Strips is the largest segment, with a share about 85%. And in terms of application, the largest application is Pharmacy Shops, followed by Public Hospital, Private Hospital, Clinics.

This report is a detailed and comprehensive analysis for global Self-Monitoring Blood Glucose (SMBG) Devices market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.

Key Features:

Global Self-Monitoring Blood Glucose (SMBG) Devices market size and forecasts, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/K Units), 2020-2031

Global Self-Monitoring Blood Glucose (SMBG) Devices market size and forecasts by region and country, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/K Units), 2020-2031

Global Self-Monitoring Blood Glucose (SMBG) Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (M Units), and average selling prices (USD/K Units), 2020-2031

Global Self-Monitoring Blood Glucose (SMBG) Devices market shares of main players, shipments in revenue ($ Million), sales quantity (M Units), and ASP (USD/K Units), 2020-2025

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Self-Monitoring Blood Glucose (SMBG) Devices

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Self-Monitoring Blood Glucose (SMBG) Devices market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Lifescan, Abbott, Terumo, Ascensia (Bayer), etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation

Self-Monitoring Blood Glucose (SMBG) Devices market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Strips
Glucose Meter
Lancet

Market segment by Application
Public Hospital
Private Hospital
Clinics
Pharmacy Shops

Major players covered
Roche
Lifescan
Abbott
Terumo
Ascensia (Bayer)

Market segment by region, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)

South America (Brazil, Argentina, Colombia, and Rest of South America)

Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Self-Monitoring Blood Glucose (SMBG) Devices product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top manufacturers of Self-Monitoring Blood Glucose (SMBG) Devices, with price, sales quantity, revenue, and global market share of Self-Monitoring Blood Glucose (SMBG) Devices from 2020 to 2025.

Chapter 3, the Self-Monitoring Blood Glucose (SMBG) Devices competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Self-Monitoring Blood Glucose (SMBG) Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.

Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Self-Monitoring Blood Glucose (SMBG) Devices market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.

Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.

Chapter 13, the key raw materials and key suppliers, and industry chain of Self-Monitoring Blood Glucose (SMBG) Devices.

Chapter 14 and 15, to describe Self-Monitoring Blood Glucose (SMBG) Devices sales channel, distributors, customers, research findings and conclusion.